peritoneal cavity. The peritoneal lesions con tain varying amounts of benign mucin and cellular material composed of mucinous epi thelium and adenocarcinoma [1] [2] [3] [4] [5] [6] [7] .
The spectrum of disease of pseudomyxoma peritonei syndrome may be separated into three clinical pathologic categories as de scribed by Ronnett and colleagues [2] . Dis seminated peritoneal adenomucinosis is a benign condition arising from appendiceal adenomas, whereas peritoneal mucinous car cinomatosis is characterized by architectural and cytologic features of adenocarcinoma.
Mucinous Appendiceal Neoplasms: Preoperative MRI
Peritoneal mucinous carcinomatosis arises from appendiceal or intestinal mucinous ade nocarcinomas. An intermediate category occurs with features inbetween those of disseminated peritoneal adenomucinosis and peri toneal mucinous carcinomatosis. The classi fication of pseudomyxoma peritonei determines the clinical course and longterm survival. The ageadjusted 5year survival for patients with disseminated peritoneal ad enomucinosis is 84% compared with 37.5% for patients with intermediate features and 6.7% for those with peritoneal mucinous carcinomatosis [2] .
At the time of pseudomyxoma peritonei diagnosis, this group of patients is very het erogeneous including benign and frankly malignant forms of mucinous appendiceal tumors. In a series of 410 patients with appen diceal tumors, only 217 were found to have disseminated peritoneal adenomucinosis at histopathologic evaluation [8] . The exact defi nition of "pseudomyxoma peritonei" is con troversial, with some authors reserving the term for patients with benign adenomucino sis. Currently, it is not possible to make this distinction at clinical presentation. The term "pseudomyxoma peritonei syndrome," there fore, includes the spectrum of possible histo pathologic entities facing the surgeon and radiologist evaluating the patient with a mu cinous appendiceal neoplasm.
The mainstay of treatment for mucinous appendiceal neoplasm with peritoneal spread is surgical cytoreduction with intraperitoneal chemotherapy [9] [10] [11] [12] [13] [14] [15] . Successful cytoreduc tion requires removal of all gross peritoneal tumors. However, complete surgical cytore duction cannot be achieved in all patients. Careful patient selection is essential because of the potential high postoperative morbidity and mortality of the procedure. Preoperative knowledge of tumor distribution, size, and histologic classification would assist the sur geon in selecting patients for surgery and planning surgery. The ultimate goal of pre operative imaging is to distinguish benign adenomucinosis (i.e., disseminated peritone al adenomucinosis) from mucinous adeno carcinoma (i.e., peritoneal mucinous carci nomatosis) and to predict the feasibility of surgical resection.
Helical CT is currently the best and most widely used preoperative imaging technique in patients with mucinous appendiceal neo plasms. However, the limited contrast range of CT makes it difficult to distinguish mucin, ascites, and solid peritoneal tumor [16] . In complete depiction of the extent of tumor on preoperative imaging can adversely affect patient management if the results of imaging are used to select patients for surgical cytore duction. For example, patients with unresect able disease may be subjected to unnecessary laparotomy if preoperative imaging underes timates the extent of tumor.
Current preoperative imaging also does not provide information about tumor histol ogy, which could affect the surgeon's deci sion to proceed with laparotomy and tumor debulking. Highgrade peritoneal mucinous carcinomatosis tumors are more likely to be invasive, thus complicating complete surgi cal resection of the tumor. To our knowledge, preoperative imaging with CT or MRI has not been used to predict the histologic type of mucinous tumor.
MRI with gadolinium enhancement has been shown to be useful for depicting perito neal metastases in patients with ovarian can cer and other tumors with intraperitoneal dissemination [17] [18] [19] [20] [21] [22] . In patients with pseudo myxoma peritonei syndrome, we hypo thesized that on fatsuppressed gadoliniumenhanced images only the solid cellular tumor would enhance, whereas the benign mucinous mate rial and ascites would not enhance (Fig. 1) ; and that the peritoneal lesions from dissemi nated peritoneal adenomucinosis and inter mediate tumors might show less pronounced enhancement than the more cellular peritone al metastases from peritoneal mucinous car cinomatosis tumors (Fig. 2) . We undertook this study in 22 patients with mucinous appen diceal neoplasms to determine the accuracy of MRI for preoperative tumor staging and A C Fig. 1 -67-year-old woman with mucinous appendiceal neoplasm. A, Delayed gadolinium-enhanced image shows marked enhancement (level 4) of bulky tumor encasing stomach, spleen, and splenic flexure (long white arrows). Enhancing right subphrenic tumor (short white arrows) and tumor in superior recess of lesser sac (black arrow) are also noted. MRI findings indicate peritoneal mucinous carcinomatosis tumor. Delayed enhancement of cellular tumor on gadolinium-enhanced MR images markedly improves tumor conspicuity in pseudomyxoma peritonei syndrome and distinguishes tumor from nonenhancing mucin and ascites. B, Coronal gadolinium-enhanced image shows confluent bulky omental and left paracolic tumor (long white arrows) surrounding splenic flexure and descending colon. Diffuse enhancing mesenteric and small-bowel serosal tumor (short thin white arrows) is present predicting incomplete surgical resection. Right subphrenic tumor (thick white arrows) and tumor encasing gastric antrum (black arrow) are also noted. Subsequent surgical cytoreduction was incomplete. C, High-power microscopic view of mucin contains large aggregates of well-differentiated adenocarcinoma. Specimen showed many tumor cells. Note cytologic atypia (arrow). Findings are that of peritoneal mucinous carcinomatosis tumor.
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classification and as a tool for predicting the feasibility of complete surgical cytoreduction.
Materials and Methods Patients
Between 1995 and 2006, MRI was performed in 38 consecutive patients with mucinous append iceal malignancy at our institution to determine the extent and distribution of peritoneal metastases. At our institution, all patients with pseudomyxoma peritonei syndrome are routinely referred for MRI. The diagnosis had been established by prior limited surgical exploration and biopsy with histo pathologic evaluation, but the patients had not undergone extensive surgical or chemotherapeutic treatment. CT scans had been obtained at other institutions, but they were not reviewed for this study. Patients were not recruited for this retro spective study. Sixteen patients who did not undergo surgical exploration were excluded. Ten patients did not undergo laparotomy because of the presence of clinically evident advanced dis ease, four patients were poor operative candidates, and two patients elected not to undergo laparo tomy. The remaining 22 patients (13 men and nine women; mean age, 60.5 years; age range, 36-81 years) underwent surgical exploration and histo pathologic evaluation within 6 weeks of MRI.
This retrospective study was approved by our institution's investigational review board, which waived requirements for written informed consent. HIPAA compliance was established. After the study, all patientidentifying data were removed from the study records to protect patient confidentiality. The fatsuppressed gadoliniumenhanced im ages were obtained in the axial plane im mediately after and 5 minutes after IV injection of 0.2 mmol/ kg of gadolinium. Delayed imaging in the coronal plane was also performed.
MRI
The selection of pulse sequences differed for the scanners. On the Philips scanner, immediate gadoliniumenhanced imaging used a 3D T1 High Resolution Isotropic Volume Examination (THRIVE) acquisition with SPIR fat suppression requiring a 21second breathhold for each 50 slices and was performed using the following para meters: 3.5/1.7; 512 × 192 matrix; NEX, 1; 6mm slice thickness with 50% slice overlap; and 10° flip angle. Delayed 2D gradientecho imaging was performed with ProSetselective (Philips Medical Systems) water excitation, requiring a 17second breathhold for each 8 slices, using the following parameters: 144/5; 512 × 228 matrix; NEX, 1; 8 to 10mm contiguous slice thickness; and 70° flip angle.
On the GE scanner, immediate and delayed dynamic gadoliniumenhanced imaging used a breathhold fatsuppressed 2D spoiled gradient echo sequence requiring a 24second breathhold for each 12 slices and was performed using the following parameters: TR range/TE range, 140-165/1.9-2.6; 512 × 192 matrix; NEX, 1; 8 to 10mmthick contiguous slices; 16 to 20kHz receiver bandwidth; and 70° flip angle. Delayed gadoliniumenhanced 2D gradientecho imaging was used on both the GE and Philips scanners. In our experience, highresolution 2D gradientecho images provide sharper image detail and better softtissue contrast than 3D gradientecho images.
Surgical Exploration
Surgical exploration and cytoreductive surgery of the abdomen and pelvis were performed in all 22 patients after MR examination. All of the laparotomies were performed by an oncologic surgeon. During laparotomy, visual inspection A C 
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and palpation of all abdominal organs, peritoneal surfaces, and bowel serosa were performed. All suspicious nodules and masses were biopsied and sent for histopathologic evaluation. Cytoreductive surgeries included omentectomy and major peri tonectomy procedures as required combined with large and smallbowel resections, gastrectomy, and splenectomy with the intention of removing all visible peritoneal and visceral tumors. Peri toneal washings were obtained for cytologic evaluation. The location, extent, and volume of abdominal and pelvic tumor and sites free of tumor were recorded from the operative notes and interviews with the surgeon. The surgeon attempted to achieve complete surgical resection of all gross tumors. On the basis of the operative reports and interviews with the surgeon after the operation, each case was categorized as complete cytoreduction if there was no gross residual tumor or as suboptimal cytoreduction if there was gross residual tumor.
Histopathologic Evaluation
Histopathologic specimens for 21 patients were retrospectively reviewed by one pathologist blinded to prior results. For the remaining patient, the original specimens were not available. Each case was categorized as disseminated perito neal adenomucinosis, intermediate, or peritoneal muci nous carcinomatosis on the basis of the microscopic features of the submitted specimens. Cases were categorized as disseminated peritoneal adeno mucinosis if there was abundant extracellular mucin and only scant simple to focally proliferative epithelium with little cytologic atypia or mitotic activity or as peritoneal mucinous carcinomatosis if the peritoneal tumors showed mucin combined with moderate to abundant cellular material composed of proliferative mucinous epithelium showing cytologic and architectural features of adenocarcinoma [2] . Cases were categorized as intermediate type if the features were inbetween those of disseminated peritoneal adenomucinosis and those of peritoneal mucinous carcinomatosis.
Review of MR Images
MR images were reviewed separately and independently by two radiologists. The T1 weighted, T2weighted, immediate gadolinium enhanced, and delayed gadoliniumenhanced images were separately reviewed for each patient to determine which sequence provided the most useful information regarding tumor staging.
Peritoneal tumor staging-For each of the four image types, the reviewers determined the presence or absence of peritoneal tumor at 13 anatomic sites, including the right subphrenic space, left sub phrenic space, gastrohepatic liga ment, lesser sac, right subhepatic space, perihepatic fissures, right paracolic gutter, left paracolic gutter, omentum, smallbowel mesentery, colon, smallbowel serosa, and pelvis. Features that were used to determine the presence of peritoneal tumor for each image type included mass effect on T1weighted images, mass effect or heterogeneity of soft tissue on T2weighted images, and enhance ment of peritoneal masses on the immediate or delayed gadoliniumenhanced spoiled gradientecho images. On the unenhanced T1 and T2weighted images, mass effect, heterogeneity, or both were used to distinguish solid peritoneal lesions of pseudomyxoma peritonei syndrome from simple ascites or mucin. The presence of ascites and mucin was also noted for each of the four image types.
Prediction of the extent of surgical cyto reduction-MR images were reviewed to deter mine the size of the tumors at each anatomic location. The tumors were categorized as < 1, 1-2, > 2-5, or > 5 cm.
The distribution of mesenteric tumor was further categorized as solitary, multifocal, or diffuse involvement of the smallbowel mesentery. Encasement of mesenteric vessels by tumor, if present, was noted. The size and distribution of tumors involving the smallbowel serosa were also noted. The distribution of smallbowel tumor was categorized as focal, multifocal, or diffuse if more than 50% of the smallbowel loops were involved by peritoneal tumors. These MRI findings were correlated with the postoperative findings of adequate versus suboptimal surgical cytoreduction of all gross tumors.
Pseudomyxoma Peritonei Tumor Classification
Qualitative assessment-Using the delayed gadoliniumenhanced images, the observers in dependently scored the degree of maximal enhancement of the dominant peritoneal mass as follows: 1, no enhancement; 2, enhancement less than or equal to liver parenchyma; 3, enhancement greater than liver parenchyma; or 4, enhancement equal to intravascular gadolinium. For cases with varied degrees of enhancement in the peritoneal lesions, the mass with the greatest degree of enhancement was assessed. Nondistended seg ments of bowel were excluded from this assess ment because enhancement of collapsed bowel can be mis leading. Linear enhancement of non thickened peritoneal surfaces was also excluded.
Quantitative assessment-A quantitative analysis of the degree of maximal tumor enhancement was also performed. On a computer workstation, the delayed gadoliniumenhanced images were evalu ated by placing separate regions of interest (ROIs) over the dominant enhancing mass, liver paren chyma, and intravascular gadolinium in the ab do minal aorta or inferior vena cava. Intrahepatic vessels were avoided when selecting the placement of the liver ROI. The mean signal intensity was measured for tumor, liver, and IV gadolinium in the abdominal aorta or inferior vena cava.
The tumortoliver contrast was calculated by dividing the mean signal intensity of the tumor by the mean signal intensity of the liver. The tumor tointravascular gadolinium contrast was calcu lated by dividing the mean signal intensity of the enhancing tumor by the mean signal intensity of IV gadolinium in the abdominal aorta or inferior vena cava.
Correlation of MR Images with Surgical and Histopathologic Findings
A sitebysite comparison of MR images and operative and histopathologic findings was per formed. Operative and histopathologic reports were reviewed for the presence of peritoneal tumors at each of the 13 anatomic sites. Information from the surgeon and the operative reports was used to determine whether tumor was present at each of the anatomic sites. Both the original written pathology reports available in all 22 patients and the results of the retrospective review of specimens in 21 patients were used. Based on these comparisons, perpatient and persite sensi tivity, specificity, and accuracy were calculated for each of the four types of MR images. Histo pathologic tumor classification was compared with the qualitative and quantitative analyses of the degree of gadolinium tumor enhancement.
Statistical Analysis
The McNemar test of correlated proportions was used to analyze persite and perpatient peritoneal tumor detection for the four types of MR images. The histologic classification versus the degree of gadolinium enhancement on delayed MR images was evaluated using the Fisher's exact test. A 2 × 2 contingency table was constructed. The disseminated peritoneal adenomucinosis tumors and intermediategrade tumors were combined in one category and were compared with the peritoneal mucinous carcinomatosis tumors. Gadolinium en hance ment levels 1 and 2 were combined as were gadolinium enhancement levels 3 and 4.
The results of the quantitative analysis of tumor enhancement were analyzed by comparing means for disseminated peritoneal adenomucinosis and intermediategrade tumors with highgrade peri toneal mucinous carcinomatosis tumors using the nonparametric MannWhitney test. MRI features used to predict adequate versus inadequate surgical resection were tested using a chisquare test for independence. Interobserver agreement was tested using the kappa analysis. In all cases, a twotailed low et al.
p value is reported with the null hypothesis rejected for p values less than 0.05.
Results

Peritoneal Tumor Staging: Site-by-Site Comparison of MRI with Surgical and Histopathologic Findings
At surgery and histopathologic evaluation, cellular peritoneal tumors, involving 232 peri toneal sites, were confirmed in all 22 patients. The delayed gadoliniumenhanced images were the most sensitive and accurate for de picting the solid peritoneal tumors of pseudo myxoma peritonei syndrome (Fig. 1) . Delayed gadolinium enhancement of solid peritoneal tumors composed of cellular mucinous epi thelium and adenocarcinoma facilitated their depiction. On the T1weighted, T2weighted, and immediate gadoliniumenhanced images, ascites, mucin, and cellular peritoneal tumor were all relatively isointense and were diffi cult to distinguish (Figs. 2-4) . Table 1 shows the persite sensitivity for the two observers in detecting cellular peritoneal tumors. For both observers, the sensitivity and accuracy of the delayed gadoliniumenhanced images were superior to T1weighted, T2 weighted, and immediate gadoliniumen hanced images (p < 0.001, McNemar test). The immediate gadoliniumenhanced images were superior to the T1weighted images (p < 0.001) but not to the T2weighted imag es (p > 0.05), and the T2weighted images were superior to the T1weighted images (p < 0.001, McNemar test).
On a perpatient basis, peritoneal tumor was depicted on T1weighted images in 80% (16/20) 
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Prediction of the Extent of Surgical Cytoreduction
Surgical cytoreduction achieved complete resection of all gross tumors in 14 patients (64%). In the remaining eight patients (36%), resection was incomplete with gross tumor remaining after surgical cytoreduction. The MRI findings that best predicted suboptimal surgical cytoreduction were the presence of large (> 5 cm) smallbowel mesenteric tu mors, which were present in 75% of the sub optimal and 0% of the complete cytoreduc tion groups (p < 0.004) (Fig. 3) ; diffuse mesenteric tumor infiltration (88% and 0%, respectively; p < 0.0002); tumor encasement of mesenteric vessels (88% and 0%; p < 0.0001); or diffuse smallbowel serosal tumor involving > 50% of the small intestine (75% and 0%; p < 0.001) ( Table 2) .
Mesenteric tumor-In the eight patients with suboptimal surgical cytoreduction, mes enteric tumors measured < 1 cm in one patient, > 2-5 cm in one patient, and > 5 cm in six patients (Fig. 3) . Mesenteric tumor dis tribution was diffuse in seven patients and multifocal in one patient (p < 0.0002). All seven patients with diffuse mesenteric tumor also showed tumor encasement of mesenteric vessels. One patient with unresectable tumor had small mesenteric tumors (< 1 cm) but also presented with diffuse smallbowel se rosal tumor (> 50% of small intestine) that precluded complete surgical tumor resection.
In the 14 patients with adequate surgical cytoreduction, MR images showed normal smallbowel mesentery in one patient, small tumors measuring ≤ 2 cm in 10 patients, and moderate tumors measuring > 2-5 cm in three patients. Mesenteric tumor distribution was focal in four patients and multifocal in nine patients (p < 0.0002). In none of the 14 pa tients with adequate surgical cytoreduction was there a large (> 5 cm) mesenteric tumor mass, diffuse mesenteric tumor infiltration, or encasement of mesenteric vessels by tumor.
Smallbowel serosal tumor- Table 2 shows the size and distribution of smallbowel tu mor. Tumor involvement of the smallbowel serosa was present in 19 patients. Patients with complete cytoreduction tended to have smaller serosal tumors than those with subop timal cytoreduction, but this difference was Note-MR findings in 22 patients were compared with surgery findings and histopathology results. a T1-weighted images were not available in two patients.
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not statistically significant. The distribution of smallbowel tumor was focal in two patients, multifocal in 11 patients, and diffuse in six patients. All six patients with diffuse tumor involving > 50% of the small bowel had tumor that was unresectable at the time of surgery. Smallvolume smallbowel serosal tumor was not depicted on MR images in three patients (Fig. 5) . For all other anatomic locations, the presence and size of tumor did not correlate with the adequacy of surgical cytoreduction.
Histologic Tumor Classification
There were six cases of disseminated peri toneal adenomucinosis (Fig. 2) , four cases with intermediate features (Fig. 3) , and 11 cases of peritoneal mucinous carcinomatosis (Fig. 4) . In general, the disseminated perito neal adenomucinosis and intermediatetype tumors had a homogeneous MR appearance, with masses or collections of mucin showing only mild gadolinium enhancement (Fig. 2) . We were unable to distinguish the dissemi nated peritoneal adenomucinosis tumors from the intermediate tumors. Microscopi cally, the intermediate tumors were typically disseminated peritoneal adenomucinosislike tumors with only isolated focal areas of adenocarcinoma (Fig. 3) .
The highgrade peritoneal mucinous car cinomatosis tumors exhibited a more com plex and heterogeneous MR appearance than the other two categories of tumor (Fig. 4) , with masses showing marked gadolinium enhancement combined with mucin and oth er softtissue masses showing mild to moder ate gadolinium enhancement. The areas of marked enhancement correlated with cellu lar adenocarcinoma mixed with mucin and varying amounts of fibrosis (Fig. 4) .
Qualitative analysis of tumor enhance ment- Table 3 shows the qualitative evaluation of the degree of maximal tumor enhancement by the two observers. Enhancement of the dominant enhancing peritoneal mass is com pared with histologic classification. Peritoneal mucinous carcinomatosis tumors showed more marked gadolinium enhancement (Figs. 1 and 4) , whereas the disseminated peritoneal adeno mucinosis and intermediatetype tumors showed less intense enhancement (Figs. 2 and 3 ).
All patients with mild gadolinium en hancement (level 1 or 2) had disseminated peritoneal adenomucinosis or intermediate tumors (Table 3) . Marked gadolinium tumor enhancement (level 4) was noted by at least one observer in 11 patients. Ten of those 11 patients had a peritoneal mucinous carcino matosis tumor at histopathologic evaluation. Moderate tumor enhancement (level 3) was noted in five patients by at least one observer. Four had peritoneal mucinous carcinomato sis tumors and one had a disseminated peri toneal adenomucinosis tumor. Level 3 or 4 tumor enhancement of the disseminated peritoneal adenomucinosis and intermediate tumors was due to focal areas of enhancing bowel in two patients. The remaining tumor masses in these patients showed only mild level 2 enhancement.
The difference in the degree of maximal tumor enhancement between the dissemi nated peritoneal adenomucinosis and inter mediatetype tumors versus the peritoneal mucinous carcinomatosis tumors was statis tically significant (p < 0.0001, Fisher's exact test). Combining the scores for the two ob servers on delayed gadoliniumenhanced im ages, a threshold of level 3 or 4 gadolinium enhancement had 100% sensitivity (22/22) , 95% accuracy (40/42), and 92% positive pre dictive value (22/24) for distinguishing peri toneal mucinous carcinomatosis tumors from disseminated peritoneal adenomucinosis and intermediate tumors.
Quantitative analysis of tumor enhance ment- Figure 6 shows the results of the quan titative evaluation of the dominant enhancing tumor compared with the liver parenchyma and intravascular gadolinium. 
discussion
Accurate preoperative evaluation of pa tients with mucinous appendiceal neoplasm can provide vital information to assist in se lecting patients for surgery and planning sur gery [23] [24] [25] [26] [27] [28] . These surgeries are challenging and have a potential for significant postop erative complications. Preoperative staging allows the surgeon to better select patients who are ideal candidates for cytoreductive surgery. Careful patient selection based on preoperative imaging studies may prevent unnecessary laparotomy in patients whose tu mor is too extensive for complete resection. The extent and distribution of mucinous tu mors determine whether complete surgical cytoreduction can be accomplished.
Currently the best method to assess the operability of pseudomyxoma peritonei tu mor is contrastenhanced CT. Jacquet et al. [28] described favorable and unfavorable CT features and found that segmental small bowel obstruction or a smallbowel or mes enteric tumor larger than 5 cm in diameter are features associated with subsequent in complete resection of pseudomyxoma perito nei tumor. These patients present significant operative challenges that may lead to exten sive smallbowel resections that result in the possible development of shortbowel syn drome and significantly increased postopera tive morbidity. In our study, the MRI features that were indicators of a poor prognosis for surgical resection included large mesenteric masses > 5 cm, diffuse mesenteric tumor infiltration, mesenteric vascular encasement, or diffuse smallbowel serosal tumors. Our current prac tice is to avoid attempting surgical resection in patients in whom MRI shows extensive tumor involving the smallbowel mesentery or smallbowel serosa. The ability of gado liniumenhanced MRI to directly show en hancing diffuse peritoneal and serosal tumor increases the accuracy of this assessment.
Tumor classification also affects the likeli hood of successful surgical cytoreduction and survival in patients with mucinous appendiceal malignancy [29] [30] [31] [32] [33] . Peritoneal mucinous car cinomatosis tumors are prone to deep invasion of the peritoneal surfaces, mesentery, and bowel serosa, resulting in incomplete surgical cytoreduction. Gadoliniumenhanced MR im ages may allow one to preoperatively predict the histologic type of tumor using either a qualitative or a quantitative evaluation of the degree of delayed gadolinium enhancement.
This MR assessment of tumor classifica tion as a function of gadolinium enhance ment reflects the cellularity of the peritoneal tumors. Peritoneal mucinous carcinomatosis tumors contain some areas that are more highly cellular and show more intense en hancement than the lesscellular disseminated peritoneal adenomucinosis and intermediate type tumors. Certainly on a persite basis, not all microscopic sites of invasive adenocarci noma showed marked gadolinium enhance ment. Qualitatively, each case of peritoneal mucinous carcinomatosis contained some highly cellular tumors showing level 3 or 4 gadolinium enhancement, whereas dissemi nated peritoneal adenomucinosis and inter mediate tumors showed lesspronounced gado linium enhancement. A quantitative mea surement of tumortoliver contrast can be used to distinguish disseminated peritoneal adenomucinosis and intermediate tumors with ratios of < 1.0 (mean, 0.67) from dissemi nated peritoneal adenomucinosis tumors with ratios of > 1.0 (mean, 1.53).
At most institutions, MDCT is the first ex amination used and therefore plays an im portant role in evaluating patients with muci nous appendiceal neoplasms. The speed and excellent spatial resolution of CT are ideally suited for abdominal imaging. However, the more limited contrast resolution of CT can present challenges in depicting subtle peri toneal tumors [19, 34] . Coakley et al. [34] noted that the sensitivity of helical CT for peritoneal tumors < 1 cm was only 25-50% compared with 85-93% for all tumors. MRI with gadolinium provides images with su perior softtissue contrast in which small peritoneal tumors and carcinomatosis are routinely depicted due to their enhancement with IV gadolinium [19] [20] [21] [22] . The sensitivity of delayed gadoliniumenhanced images for depicting subtle peritoneal tumor is well established. In one study, the sensitivity of gadoliniumenhanced MR images for depict ing peritoneal tumors < 1 cm was 85-90% compared with 22-33% for CT [19] . The overall sensitivity of MRI for depicting peri toneal tumors of all sizes was 84% in our study compared with 54% for CT [19] .
The limitations of our study should be ac knowledged. Our study was retrospective and included a relatively small number of patients with pseudomyxoma peritonei syndrome. A study with a larger number of patients is need ed to confirm our observations. A direct com parison of gadoliniumenhanced MRI and helical CT would be useful but was beyond the scope of this retrospective study. Our ob servations regarding tumor classification and maximal gadolinium enhancement may be altered by fibrosis or postoperative changes, which also may result in areas of gadolinium enhancement. Limitations due to technical factors may have introduced bias in detection rates. For instance, the delayed gadolinium enhanced 2D gradientecho images used a thicker slice thickness than the immediate 3D gradientecho images.
In conclusion, in the evaluation of patients with mucinous appendiceal neoplasms, MRI provides important information regarding preoperative staging, tumor classification, and patient selection for surgical resection. Measurements of mean signal intensity were made on workstation by placing region of interest over enhancing tumor, liver parenchyma, and abdominal aorta or inferior vena cava.
